scispace - formally typeset
A

Abigail Fraser

Researcher at University of Bristol

Publications -  304
Citations -  18381

Abigail Fraser is an academic researcher from University of Bristol. The author has contributed to research in topics: Pregnancy & Population. The author has an hindex of 64, co-authored 267 publications receiving 15147 citations. Previous affiliations of Abigail Fraser include University of Glasgow & University of London.

Papers
More filters
Journal ArticleDOI

Cohort Profile: The ‘Children of the 90s’—the index offspring of the Avon Longitudinal Study of Parents and Children

TL;DR: The Avon Longitudinal Study of Parents and Children (ALSPAC) is a transgenerational prospective observational study investigating influences on health and development across the life course and is currently set up as a supported access resource.
Journal ArticleDOI

Cohort Profile: The Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort

TL;DR: The Avon Longitudinal Study of Children and Parents (ALSPAC) was established to understand how genetic and environmental characteristics influence health and development in parents and children.
Journal ArticleDOI

The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis.

TL;DR: In this article, the authors conducted a systematic review and meta-analysis of all studies reporting a prevalence of NAFLD based on any diagnostic method in participants 1-19 years old, regardless of the main aim of the study.
Journal ArticleDOI

Association of maternal weight gain in pregnancy with offspring obesity and metabolic and vascular traits in childhood.

TL;DR: Greater maternal prepregnancy weight and gestational weight gain up to 36 weeks of gestation are associated with greater offspring adiposity and adverse cardiovascular risk factors.
Journal ArticleDOI

Meta-analysis : Antibiotic prophylaxis reduces mortality in neutropenic patients

TL;DR: This meta-analysis summarizes 95 randomized trials of antibiotic prophylaxis in 9283 afebrile neutropenic patients with conditions such as hematologic cancer and found that fluoroquinolones reduced the risk for fever, infections, and all-cause and infection-related mortality.